Summary
Intramuscular administration of ketamine at 15-20 mg/kg bodyweight provided effective levels of anaesthesia for venipuncture in 23 chimpanzees aged months. For procedures such as plasmaphereses or percutaneous needle biopsy requiring longer anaesthetic times, xylazine (l mg/kg) was given with the ketamine. More than 1600 procedures were performed under anaesthesia on the 23 chimpanzees over a period of 18 months with no mortality. Recovery was smooth and uneventful.
The chimpanzee is an important but expensive surrogate for man in the investigation of disease. As a model for the study of viral hepatitis, the close physiological and phylogenetic relationship to man, and the fact that no other suitable in vitro system has yet been found for the study of the hepatitis B virus or the agents of human non-A, non-B hepatitis, makes the chimpanzee invaluable.
Safe and effective anaesthesia are necessary. With the removal of phencylidine from the market and the increased experimental use of the chimpanzee, the need for a new, safe, rapid, and nontoxic intramuscularly injectable anaesthetic became apparent. Although this project was not designed to study the biochemical effects and the anaesthetic parameters of the agents described, it provided clinical information about the use of ketamine and ketamine-xylazine in combination for effective restraint and safe anaesthesia of juvenile chimpanzees.
Materials and Methods
The chimpanzees (Pan troglodytes) were born in a breeding colony (International Center for Environmental Safety, Alamogordo, USA; FDA Contract 223-77-1044). From birth until 12 months old they were housed in a nursery designed and maintained for the care and raising of young chimpanzees (Barker et al., 1973) . At 12 months of age, the chimpanzees were transported to the Bureau of "Biologics at Bethesda. They were placed in individual cages and conditioned to the primate facility for a minimum of 30 days. During this time they were bled weekly to monitor serological evidence of exposure to human viral hepatitis and to gather baseline data for future reference. After quarantine, the chimpanzees were assigned to an experimental study protocol.
Over a period of 2 years 23 chimpanzees were studied after being injected with sera from human patients, or plasma derivatives, or chimpanzee sera containing hepatitis viruses. The animals were 12-36 months of age and weighed 7-15 kg. Each chimpanzee was anaesthetized weekly for routine venipuncture of the femoral vein and percutaneous liver biopsy using a 2'1 mm diameter (14 gauge) Vim-Silverman biopsy needle. Complete blood counts and weights were obtained monthly to monitor the general health and to assess the weight gain of these young animals (Tabor, April, Seeff & Gerety, 1979a, b) .
Ketamine ('Ketaset'; Bristol, Syracuse, USA) was administered im at a dosage of 15-20 mg/kg. For procedures requiring longer periods of anaesthesia, such as more extensive blood withdrawal, plasmaphereses, or liver biopsies, xylazine ('Rompun'; Chemagro, Kansas City, USA) at a dose of 1 mg/kg was combined with the ketamine, and administered im as a single injection. Atropine sulphate (2-5 mg single injection) was administered im to animals previously identified as exhibiting excessive salivation during anaesthesia, but this was not usually necessary. To prevent vomiting and aspiration pneumonia, food was removed from the animals 12-15 h prior to anaesthesia, nor were they allowed to eat until complete recovery from the effects of anaesthesia had been observed. The average time to full recovery was 1 h after injection of ketamine, and 2 h after the ketamine-xylazine combination.
Anaesthesia of chimpanzees

Results
Ketamine alone produced adequate anaesthesia for venipuncture 3-5 min after injection. Pain was evident upon im injection of ketamine, but the degree of response varied with the individual. No swelling or inflammation was observed at the site of injection. Induction was smooth and rapid without abnormal reflexes or cataleptoid episodes. Vital signs such as heart and respiratory rates and body temperature remained within normal ranges both during and after anaesthesia (Butler, 1973) . There was adequate relaxation, sedation, and analgesia for the procedures to be performed. The anaesthetic state lasted 10-15 min, which was sufficient for routine venipuncture and inoculation procedures. The recovery phase was calm, without spasmodic or convulsive episodes. The chimpanzees showed signs of awareness 20-30 min after injection, and recovered in 45-60 min. The majority of the animals remained in a quiet state after recovery and exhibited normal motor and sensory reflexes with natural movements (Fine & Finestone, 1973) .
The combination of ketamine and xylazine injected simultaneously im produced similar but rather deeper anaesthesia. Although pain was evidenced on injection, there was no prolonged irritation or inflammation at the site of injection. The associated clinical signs during the induction and recovery periods were similar to those seen with ketamine alone.
Although the induction time for the combination was the same as ketamine alone, the duration of the anaesthesia and the recovery period were approximately doubled. Greater muscular relaxation and analgesia were obtained with the ketaminexylazine combination than with ketamine alone.
Restlessness and movement occurred less frequently during the recovery period, and this was particularly true when the combination was used in larger, older animals. The extended recovery period also allowed more time for manipulation of the larger chimpanzees after the procedures were completed.
Although laryngeal and pharyngeal reflexes remainecj intact during anaesthesia, an animal in dorsal recumbancy would occasionally suffer from lingual obstruction with resulting respiratory difficulty. Once the airway was cleared and the head supported the problem was eliminated. Insertion of a paediatric-size 'oral airway' was adequate prevention. At the dosage level of ketaminexylazine employed endotrachael intubation was not possible. Individual chimpanzees varied in response (palpebral, corneal and pain reflexes) to external stimuli while under the influence of ketamine or the ketamine-xylazine combination.
Neither the ketamine nor the combination of ketamine and xylazine produced a toxic effect 117 in the liver as detected by chemical and histopathological' analyses prior to or during experimental infection with hepatitis viruses (Tabor et al., 1979a, b) . Weekly aminotransferase (AST, ALT) levels and monthly complete blood counts of the chimpanzees remained in normal pretreatment ranges (Wisecup, Hodson, Hanley & Felts, 1969) .
Discussion
The dosage of 15-20 mg/kg ketamine with 1 mg x:ylazine/kg when combined and injected simultaneously im produced rapid, predictable and effective anaesthesia with minimal discomfort locally and with no apparent cumulative effects. Allergic reactions or individual intolerance to this drug combination were not observed, and recovery was uneventful.
Ketamine and xylazine were selected because of their previous record of safe use for clinical anaesthesia in other laboratory animals, and because of knowledge of their pharmacological effects (Banknieder Phillips Jackson & Vinal, 1978) . The com-binati~n induces rapid sedation with good analgesia and adequate muscular relaxation, the extent of which is dose dependent. These 2 drugs specifically met our needs since neither was known to offer hepatic toxicity or interfere with liver metabolism -of considerable importance for the success of research projects involving infection of the liver (Cramlet & Jones 1976) . The criteria for clinical use of these short-acting anaesthetic agents in addition to the above characteristics were ease of induction, cardiopulmonary stability, adequate analgesia of reliable duration, and uneventful recovery.
The physical condition of these chimpanzees remained excellent throughout the study and the behavioural status of most was stable. There seemed a progressively increased tolerance to ketamine when used alone over a period of time, irrespective of bodyweight gain. Xylazine in combination with ketamine may have masked this effect due to its more pronounced central suppression (Banknieder et al., 1978) . Increased adrenergic or cholinergic activity in excitable animals prior to injection of the anaesthetic may account for the variable anaesthetic times between individuals. The anaesthetic regimen of ketamine-xylazine described here is suitable for minor procedures in chimpanzees.
